Insulin sensitivity can be measured through simple blood tests, calculated ratios, or specialized clinical procedures, depending on how precise you need the answer to be. The most accessible option for most people is a fasting insulin and glucose blood draw, which takes minutes and costs relatively little. More advanced methods exist for research or complex clinical situations, but a combination of basic labs can give you a surprisingly clear picture of where you stand.
Fasting Insulin: The Simplest Starting Point
A fasting insulin test measures how much insulin your pancreas releases just to maintain normal blood sugar while you haven’t eaten. The logic is straightforward: if your body needs a lot of insulin to keep glucose in check, your cells aren’t responding to insulin efficiently. If it needs very little, your cells are sensitive to it.
There are no official clinical guidelines for “normal” fasting insulin, and major organizations like the American Diabetes Association don’t include it in their standard screening recommendations. That said, a general consensus among clinicians who do test it looks like this:
- Below 10 µIU/mL: Often considered optimal
- Below 20 µIU/mL: Generally considered good
- 25 to 35 µIU/mL: Considered fair, worth monitoring
- Above 40 µIU/mL: May indicate early insulin resistance
To get an accurate reading, you need to fast for 8 to 12 hours before the blood draw. If you take biotin supplements (vitamin B7), stop them at least a day before testing, as they can interfere with results. Intense exercise the day before can also temporarily improve insulin sensitivity and skew your numbers lower than your true baseline.
HOMA-IR: Combining Insulin and Glucose
The Homeostatic Model Assessment for Insulin Resistance, or HOMA-IR, pairs your fasting insulin with your fasting glucose to produce a single number. The formula is fasting insulin (µIU/mL) multiplied by fasting glucose (mg/dL), divided by 405. Your doctor can calculate it from the same blood draw used for fasting insulin.
HOMA-IR is the most widely used formula in both research and clinical practice. In U.S. settings, values between 2.0 and 3.0 are commonly used as thresholds, with the NHANES cutoff of 2.5 or higher indicating insulin resistance. In Asian populations, the threshold is typically lower, ranging from 1.4 to 2.5. A HOMA-IR below 1.0 generally signals strong insulin sensitivity.
The limitation is that HOMA-IR captures only what’s happening in the fasting state. It tells you how hard your pancreas works overnight to keep glucose stable, but it doesn’t reveal how your body handles a meal or a sugar load.
QUICKI: A Logarithmic Alternative
The Quantitative Insulin Sensitivity Check Index uses the same two blood values as HOMA-IR but runs them through a different formula: 1 divided by the sum of log(fasting insulin) plus log(fasting glucose), with insulin in µIU/mL and glucose in mg/dL. QUICKI correlates well with more advanced testing and is sometimes preferred in research for its statistical properties.
Values below 0.335 suggest insulin resistance. This cutoff has been validated in studies of women with polycystic ovary syndrome (PCOS) and other metabolic conditions. Higher numbers mean better sensitivity.
Triglyceride-to-HDL Ratio: No Extra Tests Needed
If you already have a standard lipid panel, you can estimate insulin sensitivity without any additional blood work. Dividing your triglycerides by your HDL cholesterol (both in mg/dL) produces a ratio that correlates meaningfully with insulin resistance.
Recommended cutoffs vary by sex and ethnicity. For women, a ratio above roughly 2.5 raises concern; for men, above 2.8. Some researchers use a stricter threshold of 3.5 as more definitively indicating resistance. In African American populations, lower cutoffs have been proposed: above 1.5 for women and above 2.0 for men. The ratio works best as a screening signal rather than a precise measurement, but it’s useful because lipid panels are so commonly ordered.
C-Peptide: When Insulin Levels Aren’t Reliable
C-peptide is a molecule released by the pancreas in equal amounts to insulin, but it stays in the bloodstream longer and isn’t affected by injected insulin. This makes it essential in two situations: when someone is already taking insulin (making direct insulin measurement meaningless) and when a doctor needs to distinguish between type 1 and type 2 diabetes.
If you’re on insulin therapy and want to know how much insulin your pancreas still produces on its own, a C-peptide test is the only reliable way to find out. It’s also used to investigate unexplained low blood sugar, since certain causes of hypoglycemia involve excessive insulin production that C-peptide can confirm.
The Kraft Insulin Survey: Tracking Your Response Over Time
Standard fasting tests miss a category of people whose blood sugar looks normal but whose insulin is working overtime to keep it that way. The Kraft test addresses this by measuring insulin levels at multiple time points during an oral glucose tolerance test, typically over three hours after drinking a glucose solution.
In 1975, researcher Joseph Kraft identified five distinct patterns of insulin response based on how high insulin peaks, when the peak occurs, and how quickly levels fall back down. A normal response shows insulin peaking at 30 or 60 minutes with fasting insulin below 30 µIU/mL, followed by a rapid decline so that the combined two-hour and three-hour insulin values stay below 60 µIU/mL. A hyperinsulinemic response shows up as elevated fasting insulin, a delayed peak at two hours or later, or a slow decline. A simplified version of this approach uses just fasting insulin plus a single two-hour insulin reading: a two-hour value above 30 µIU/mL after the glucose load suggests hyperinsulinemia even when glucose itself appears normal.
This kind of testing can catch insulin resistance years before fasting glucose or HbA1c becomes abnormal, which is why some clinicians advocate for it in people with a family history of type 2 diabetes or metabolic syndrome.
The Euglycemic Clamp: The Research Gold Standard
The hyperinsulinemic euglycemic clamp is the most precise measurement of insulin sensitivity available, but it’s almost exclusively used in research settings. During the procedure, insulin is infused intravenously at a constant rate while glucose is simultaneously infused and adjusted every few minutes to keep blood sugar at a fixed, normal level. The key measurement is how much glucose has to be infused to prevent blood sugar from dropping. A person with high insulin sensitivity requires a large amount of glucose to compensate for insulin’s strong effect, while a resistant person needs very little.
The procedure takes several hours, requires intravenous lines, and involves frequent blood sampling. Radioactive glucose tracers can be added to measure how much glucose the liver produces during the test, separating liver insulin resistance from muscle insulin resistance. It’s invaluable for drug development and metabolic research, but impractical for routine clinical use.
Choosing the Right Method
For most people, a fasting insulin level combined with HOMA-IR gives a solid baseline. These require a single blood draw and can be ordered by almost any doctor. If you already have lipid results, checking your triglyceride-to-HDL ratio adds another data point at no extra cost.
If your fasting numbers look borderline or normal but you have risk factors like abdominal weight gain, a family history of diabetes, or PCOS, a glucose tolerance test with insulin measurements at multiple time points provides a more complete picture. This is the version most likely to catch early insulin resistance that fasting tests miss.
Whichever method you use, a single measurement is less useful than tracking changes over time. Insulin sensitivity shifts with weight, physical activity, sleep, and stress. Repeating your preferred test every 6 to 12 months gives you a trend line that’s far more informative than any isolated number.